Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07558473 · ClinicalTrials.gov registry record · NA
Measuring Brain Changes Following Cognitive Intervention in Pediatric Patients With Brain Tumors
A NA study, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- Not yet
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT07558473: Clinical Trial NA study, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
NCT07558473 is a NA study that has not yet begun recruiting, run by Hugo W. Moser Research Institute at Kennedy Krieger. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07558473, a NA study, has not yet begun recruiting, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
The goal of this study is to learn if an online computerized training program improves processing speed in children with pediatric brain tumors. The main questions it aims to answer are: 1. Is the cognitive intervention feasible to administer to children with brain tumors during and after cancer treatment? 2. Is the cognitive intervention acceptable to patients and caregivers? 3. Does the cognitive intervention improve neuropsychological functioning? There is no comparison group for this study. Participants will: 1. Complete 15 minutes of online computerized cognitive training 5 times a week for 8 weeks. 2. Have weekly check-ins with the cognitive coach. 3. Fill out acceptability surveys at the end of the cognitive intervention. 4. Complete pre- and post- neuropsychological testing.
Primary Outcome
Study enrollment rate.
Interventions
- BEHAVIORAL Online computerized cognitive training intervention focused on processing speed.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2026-07-30 |
| Est. Completion | 2033-04-01 |
| Phase | NA |
What is known before NCT07558473 opens enrollment
NCT07558473 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 1 intervention - of which Online computerized cognitive training intervention focused on processing speed. is the first listed.
NCT07558473 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07558473 about?
NCT07558473 is a clinical study titled "Measuring Brain Changes Following Cognitive Intervention in Pediatric Patients With Brain Tumors". The goal of this study is to learn if an online computerized training program improves processing speed in children with pediatric brain tumors. The main questions it aims to answer are: 1. Is the cognitive intervention feasible to administer to children with brain tumors during and after cancer tr...
What is the current status of trial NCT07558473?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2026-07-30. Estimated completion is 2033-04-01.
What interventions are being tested in trial NCT07558473?
The interventions under investigation include: Online computerized cognitive training intervention focused on processing speed. (BEHAVIORAL).
Who is sponsoring clinical trial NCT07558473?
This trial is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07558473's enrollment target sits among peer trials
300 330th of 2000 higher than 1,630 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI